Massive stroke drug study shows promise in routine care
Disease control
Completed
This study tested a clot-busting drug called non-immunogenic staphylokinase in over 23,000 adults who had an acute ischemic stroke. The goal was to see how safe and effective the drug is in everyday hospital settings. Patients received the drug within 4.5 hours of symptoms starti…
Sponsor: Supergene, LLC • Aim: Disease control
Last updated May 04, 2026 16:20 UTC